- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 49 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 5 residues within 4Å:- Chain A: X.57, X.58
- Chain C: E.92, N.93
- Chain D: S.17
Ligand excluded by PLIPNAG.5: 1 residues within 4Å:- Chain C: N.138
Ligand excluded by PLIPNAG.6: 3 residues within 4Å:- Chain C: N.142, I.327, G.328
Ligand excluded by PLIPNAG.7: 5 residues within 4Å:- Chain C: V.139, N.141, N.153, L.172, D.325
Ligand excluded by PLIPNAG.8: 1 residues within 4Å:- Chain C: N.157
Ligand excluded by PLIPNAG.9: 2 residues within 4Å:- Chain C: R.197, N.202
Ligand excluded by PLIPNAG.10: 5 residues within 4Å:- Chain C: N.239, T.241, S.279, E.280, I.282
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: X.62
- Chain C: D.235, T.245, N.246
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain C: N.281, T.283
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain C: E.274, N.294, E.295
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain C: N.306, I.327
Ligand excluded by PLIPNAG.15: 6 residues within 4Å:- Chain C: N.300, T.302, H.334, N.336, T.418, R.447
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain C: N.267, N.451
- Ligands: NAG-NAG-BMA.1
Ligand excluded by PLIPNAG.17: 6 residues within 4Å:- Chain C: Q.298, N.300, N.336, V.337, S.338, R.447
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain C: T.376, N.390, S.392
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain D: N.100, T.102
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain D: N.107, S.109, E.110
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain D: N.126, Y.127
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain E: E.92, N.93
- Chain G: S.17
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain E: N.138, K.152, Y.196
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain E: V.139, N.141, N.153, L.172
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain E: Q.135, F.156, N.157
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain E: N.239, T.241, S.279
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain E: E.272, E.273, N.294, E.295, K.348
Ligand excluded by PLIPNAG.28: 7 residues within 4Å:- Chain E: Q.298, N.300, N.336, V.337, S.338, S.416, R.447
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain E: N.306, I.327, V.445
Ligand excluded by PLIPNAG.30: 6 residues within 4Å:- Chain E: N.300, C.301, T.302, H.334, N.336, T.418
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain E: S.296, N.451
- Ligands: NAG-NAG-BMA.2
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain E: N.281, T.283, N.284
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain E: N.390, S.392
Ligand excluded by PLIPNAG.34: 7 residues within 4Å:- Chain E: V.179, I.181, L.198, I.199, N.200, N.202
- Chain H: R.313
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain E: N.343, L.346, N.396, S.397, W.399
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain F: N.100, T.102
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain F: K.122, E.123, S.125, N.126
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain H: N.93
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain H: T.137, N.138, K.194
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain H: V.139, N.153, Y.170, D.325
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain H: Q.135, S.155, F.156, N.157
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain H: W.101, N.239, T.241, S.279
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain H: H.90, K.234, N.246
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain H: N.281, T.283, N.284
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain H: E.273, N.294, E.295, K.348
Ligand excluded by PLIPNAG.46: 6 residues within 4Å:- Chain H: Q.298, N.300, N.336, V.337, S.338, R.447
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain H: N.306
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain H: N.300, T.302, N.336, R.447
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain H: T.377, N.390
- Ligands: NAG.52
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain H: N.396
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain H: N.267, S.296, N.451
- Ligands: NAG-NAG-BMA.3
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain H: N.367, S.368, S.369
- Ligands: NAG.49
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, C.A. et al., Focusing antibody responses to the fusion peptide in rhesus macaques. Biorxiv (2023)
- Release Date
- 2023-07-26
- Peptides
- FP1 heavy chain: A
FP1 light chain: B
BG505 Boost 2 gp120: CEH
BG505 Boost 2 gp41: DFG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CH
FD
BF
DG
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 49 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, C.A. et al., Focusing antibody responses to the fusion peptide in rhesus macaques. Biorxiv (2023)
- Release Date
- 2023-07-26
- Peptides
- FP1 heavy chain: A
FP1 light chain: B
BG505 Boost 2 gp120: CEH
BG505 Boost 2 gp41: DFG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CH
FD
BF
DG
E